Life sciences firm Harvard Apparatus Regenerative Technology of Holliston will work with a Connecticut hospital to develop a way to fix or replace a child’s esophagus to treat life-threatening conditions, the Holliston firm announced Monday.
Harvard Apparatus (HART) which develops bioengineered organs for life-threatening conditions, will work with Connecticut Children’s Medical Center, based in Hartford, Conn. The two organizations have collaborated before.
“We are proud to continue and expand our collaboration with Connecticut Children’s Medical Center to develop new treatment options for children using regenerative medicine principles,” said Jim McGorry, HART’s president and CEO. “Dr. Christine Finck (the medical center’s chief of pediatric surgery) and her team are recognized leaders in the regenerative medicine community, well-known for their passion and commitment to bringing new treatments to children and their families.”
One of the conditions to be treated is esophageal atresia, a statement from HART said. Esophageal atresia is a rare disorder, affecting 1 in 2,500 to 3,500 babies, in which a child is born without a portion of his or her esophagus.
